CIPA Guide to the Patents Acts - 8th Edition

CIPA Guide to the Patents Acts - 8th Edition

Christopher LaHatte

Book

$465.00* RRP + GST

Date: 19/02/2016

Code: 9780414050464

Sweet & Maxwell, UNITED KINGDOM

Available Formats

Format Title Date Code Price (excl. GST)
Book CIPA Guide to the Patents Acts - 8th Edition 19/02/2016 9780414050464 $465.00 Add to cart

Description

The CIPA Guide To the Patents Act - 8th Edition, is a must-have for any practitioner advising about patents.

The Guide brings together the expertise of over 25 highly respected professionals including patent attorneys, solicitors and members of the Bar, all individually selected for their expert knowledge.

  • Sets out the acts section by section and, where appropriate, the Features the Patents Act, 1977 and relevant provisions of the Copyright, Designs and Patents Act, 1988 together with relevant EU treaties and directives
  • Includes the full text of the Acts, section-by-section
  • Provides the corresponding provisions of the Paris Convention, the TRIPS Treaty, the PCT and the EPC
  • Includes the UK Patents Rules and the Civil Procedure Rules and Practice Directions relevant to each section
  • Features the decisions relevant to each section of the UK IP Office and courts and of the EPO Appeal Boards
  • Includes selected decisions of the US courts
  • Provides a detailed commentary and analysis of the practical working of each section and of the significance of the decisions handed down under it
  • Features coverage of developments in the fields of software, biotechnology and supplementary protection certificates for pharmaceuticals
  • Refers to over 3300 decided cases

NEW TO THIS EDITION

The 8th edition offers coverage of legislative and jurisprudence developments to end June 2015, including:

  • Amendments introduced by recent legislation including the Intellectual Property Act, 2014, the Patents (European Patent with Unitary Effect and Unified Patents Court) Order 2015, the Patents (Amendment) Rules 2014 and updates to CPR Practice Direction 63.
  • Substantial commentary on landmark decisions including:
  • Generics (UK) Ltd t/a Mylan v Warner Lambert [2015] EWHC 2548 (Pat) (second medical use claims)
  • Lantana Ltd v Comptroller General of Patents [2014] EWCA Civ 1463 (patentable subject matter)
  • Aga Medical Corp v Occlutech (UK) Ltd [2014] EWHC 2506 (Pat) (confidentiality)
  • Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) (obviousness; common general knowledge)
  • Idenix v Gilead [2014] EWHC 3916 (generic claim for pharmaceutical compounds; rationale supporting effectiveness)
  • International Stem Cell Corporation (Judgment) [2014] EUECJ C-364/13 (human embryo)
  • Eli Lilly & Company v Human Genome Sciences Inc [2014] EWHC 2404 (Pat) (SPC regulation)
  • T 1363/12 SAMSUNG/Reinforcement (test for added subject-matter)
  • G 3/14 Examination of clarity objections G 2/12 Tomatoes II and G 2/13 Broccoli II (product claims; essentially biological processes)

Commentary on the many other decisions recently handed down which may be relevant to specific practice issues.

*

Please note: This is an international title and will be sent directly from its publisher. Please allow 3 - 4 weeks for delivery.